Skip to main content
Signal8
Matushansky Igor profile photo

Igor Matushansky

CIK: 0001768208

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Immuneering Corp logo
IMRX

Immuneering Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Feb 3, 2026
    Award(A)

    Stock Option

    Direct
    140K shares-
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Mar 21, 2025
    Award(A)

    Stock Option

    Direct
    118K shares-

1-2 of 2

About Matushansky Igor

Matushansky Igor (SEC CIK 0001768208) files insider reports with the SEC as Chief Medical Officer of Immuneering Corp (IMRX).

Signal8 holds 3 ownership filings by Matushansky Igor (1 Form 3, 2 Form 4), filed between Mar 24, 2025 and Feb 5, 2026. Those filings report 2 transactions, from Mar 21, 2025 to Feb 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Matushansky Igor's filings is in CAMBRIDGE, MA.

Recent filings by Matushansky Igor

  • Feb 3, 2026: Grant or award of IMRX derivative securities (Form 4, code A).
  • Mar 21, 2025: Grant or award of IMRX derivative securities (Form 4, code A).

Other insiders filing for Immuneering Corp (IMRX)

How to read Form 4 transaction codes